NASDAQ: INO - Inovio Pharmaceuticals, Inc.

Yield per half year: -79.26%
Dividend yield: 0.00%
Sector: Healthcare

Inovio Pharmaceuticals, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -4.12 -100%
P/S 11.73 33.77 -65.27%
P/BV 0.0831 4.83 -98.28%
P/FCF -0.9496 61 -101.56%
Ev/Ebitda -0.1948 -22.17 -99.12%
Ev/S 30.83 22.57 36.6%
Ev/FCF -0.2058 68.76 -100.3%
E/P -1.14 0.0178 -6513.98%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-15831.92 4.97 -318517.04% -7687.03 +105.96%
ROE -115.14 9.61 -1297.94%
ROA -78.13 0.3443 -22794.4%
ROIC -65.69 7.63 -960.45%
ROS -16239.87 -25.17 64420.44%
ROCE -115.23 15.45 -845.88%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.2293 -3.68 -93.76% -0.184 +24.65%
Nеt Debt/Ebitda -0.1207 -3.44 -96.49%
Debt/Ratio 0.1747 0.1986 -12.04%
Debt/Equity 3.92 1.66 136.01%
Debt/Net Income -0.2236 10.32 -102.17%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.541 -100% 0 0%
Number of years of dividend growth 1 0.7368 35.71%
DSI 0.5 0.2256 121.67%
Average dividend growth 0 0.9598 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.541

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-79.71 -57.64 38.29%
Growth impulse Ebitda in 5 years 23.48 -90.94 -125.82%
Growth impulse Net Income in 5 years 12.04 -97.8 -112.31%
Growth impulse FCF in 5 years 26.2 -108.72 -124.1%
Growth impulse EPS in 5 years 399.47 -142.05 -381.22%
IP Score
3.6/10

Similar companies

DENTSPLY SIRONA

Alexion

Amgen

ABIOMED

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription